Briefing

Featured article

China’s drugs offer lifeline for global pharma as it peers over the patent cliff

Also in this section

News in Numbers

Latest News

Latest Deals

10/22/2025 09:58:44
  • Home | Cleanroom chronicles
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • EMBOCAPS Company Insight
  • EMBOCAPS
  • Nipro
  • Syngene Company Insight
  • In Depth
  • Cleanrooms reimagined: Inside pharma manufacturing’s new era
  • Sustained interest? Biopharma’s green manufacturing gains traction
  • Bioproduction booms: How innovation is redefining biologics, vaccines and therapeutics
  • From Nobel to next-gen: Sweden’s quiet life sciences ascent
  • ESMO25: Keytruda combo defies doubt, delivers PFS and OS gains in ovarian cancer
  • ‘The time of the Einsteins is over’: Pharma urged to rethink trials for 2050
  • Biopharmaceutical industry cold-chain networks an innovation hotbed
  • DrM Company Insight
  • Steris
  • Listings
  • Events
  • Excellence Awards
  • Buyer's Guides
  • Next issue
10/27/2025 00:00:00